Wed, Aug 20, 2014, 11:23 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • terry_amln terry_amln Jun 13, 2013 3:42 PM Flag

    Supreme Court rules human genes cannot be patented

    Myriad Genetics, the company at the center of a Supreme Court decision saying human genes cannot be patented,

    Investors' initial positive feelings about having the Supreme Court ruling behind them might be fleeting, says Daniel Leonard of Leerink Swann in a note to clients. Investors will soon focus on the fact that with more competition, Myriad's "dominant" market share "has nowhere to go but down," Leonard wrote. He points out that others rivals, including BRLI, University of Washington and Ambry Genetics have already stated they have plans to get into the business. Myriad's patents were due to expire in December 2015 regardless of the decision, Leonard says.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GHDX
28.03+0.07(+0.25%)Aug 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.